• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 大流行对瑞士重症监护病房血培养阳性的流行病学影响:一项全国性监测研究。

The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study.

机构信息

Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Division of Infectious Diseases, Regional Hospital Lugano, Lugano, Switzerland.

出版信息

Crit Care. 2021 Nov 22;25(1):403. doi: 10.1186/s13054-021-03814-z.

DOI:10.1186/s13054-021-03814-z
PMID:34809698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8607066/
Abstract

BACKGROUND

Evidence about the impact of the pandemic of COVID-19 on the incidence rates of blood cultures contaminations and bloodstream infections in intensive care units (ICUs) remains scant. The objective of this study was to investigate the nationwide epidemiology of positive blood cultures drawn in ICUs during the first two pandemic waves of COVID-19 in Switzerland.

METHODS

We analyzed data on positive blood cultures among ICU patients, prospectively collected through a nationwide surveillance system (ANRESIS), from March 30, 2020, to May 31, 2021, a 14-month timeframe that included a first wave of COVID-19, which affected the French and Italian-speaking regions, an interim period (summer 2020) and a second wave that affected the entire country. We used the number of ICU patient-days provided by the Swiss Federal Office of Public Health as denominator to calculate incidence rates of blood culture contaminations and bloodstream infections (ICU-BSI). Incidence rate ratios comparing the interim period with the second wave were determined by segmented Poisson regression models.

RESULTS

A total of 1099 blood culture contaminations and 1616 ICU-BSIs were identified in 52 ICUs during the study. Overall, more episodes of blood culture contaminations and ICU-BSI were observed during the pandemic waves, compared to the interim period. The proportions of blood culture contaminations and ICU-BSI were positively associated with the ICU occupancy rate, which was higher during the COVID-19 waves. During the more representative second wave (versus interim period), we observed an increased incidence of blood culture contaminations (IRR 1.57, 95% CI 1.16-2.12) and ICU-BSI (IRR 1.20, 95% CI 1.03-1.39).

CONCLUSIONS

An increase in blood culture contaminations and ICU-BSIs was observed during the second COVID-19 pandemic wave, especially in months when the ICU burden of COVID-19 patients was high.

摘要

背景

关于 COVID-19 大流行对重症监护病房(ICU)中血培养污染和血流感染发生率影响的证据仍然很少。本研究的目的是调查瑞士 COVID-19 大流行的前两个浪潮期间 ICU 中抽取的阳性血培养的全国流行病学情况。

方法

我们分析了 2020 年 3 月 30 日至 2021 年 5 月 31 日期间,通过全国性监测系统(ANRESIS)前瞻性收集的 ICU 患者阳性血培养数据,该时间段为 14 个月,包括 COVID-19 的第一波,影响了法语和意大利语区,一个中间期(2020 年夏季)和第二波,影响了整个国家。我们使用瑞士联邦公共卫生办公室提供的 ICU 患者住院日数作为分母来计算血培养污染和血流感染(ICU-BSI)的发病率。使用分段泊松回归模型确定中间期与第二波相比的发病率比。

结果

在研究期间,52 个 ICU 中发现了 1099 例血培养污染和 1616 例 ICU-BSI。总体而言,与中间期相比,大流行期间观察到更多的血培养污染和 ICU-BSI 事件。血培养污染和 ICU-BSI 的比例与 ICU 入住率呈正相关,而 COVID-19 期间的 ICU 入住率更高。在更具代表性的第二波(与中间期相比)中,我们观察到血培养污染的发病率增加(IRR 1.57,95%CI 1.16-2.12)和 ICU-BSI(IRR 1.20,95%CI 1.03-1.39)。

结论

在第二波 COVID-19 大流行期间,观察到血培养污染和 ICU-BSI 的增加,尤其是在 COVID-19 患者 ICU 负担高的月份。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd52/8607605/c66286aa02f7/13054_2021_3814_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd52/8607605/f740e6f678a1/13054_2021_3814_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd52/8607605/c0d6cf7586f5/13054_2021_3814_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd52/8607605/c66286aa02f7/13054_2021_3814_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd52/8607605/f740e6f678a1/13054_2021_3814_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd52/8607605/c0d6cf7586f5/13054_2021_3814_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd52/8607605/c66286aa02f7/13054_2021_3814_Fig3_HTML.jpg

相似文献

1
The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study.COVID-19 大流行对瑞士重症监护病房血培养阳性的流行病学影响:一项全国性监测研究。
Crit Care. 2021 Nov 22;25(1):403. doi: 10.1186/s13054-021-03814-z.
2
Epidemiology of bloodstream infections caused by extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae in Switzerland, 2015-2022: secular trends and association with the COVID-19 pandemic.瑞士 2015-2022 年耐广谱头孢菌素的大肠埃希菌和肺炎克雷伯菌引起的血流感染的流行病学:长期趋势及与 COVID-19 大流行的关联。
J Hosp Infect. 2024 Aug;150:145-152. doi: 10.1016/j.jhin.2024.05.013. Epub 2024 Jun 3.
3
Surveillance of bloodstream infections in intensive care units in England, May 2016-April 2017: epidemiology and ecology.英格兰重症监护病房血流感染监测,2016 年 5 月-2017 年 4 月:流行病学和生态学。
J Hosp Infect. 2020 Sep;106(1):1-9. doi: 10.1016/j.jhin.2020.05.010. Epub 2020 May 16.
4
No increase of device associated infections in German intensive care units during the start of the COVID-19 pandemic in 2020.2020 年 COVID-19 大流行期间,德国重症监护病房并未出现与设备相关的感染增加。
Antimicrob Resist Infect Control. 2022 May 7;11(1):67. doi: 10.1186/s13756-022-01108-9.
5
Epidemiology, time course, and risk factors for hospital-acquired bloodstream infections in a cohort of 14,884 patients before and during the COVID-19 pandemic.在 COVID-19 大流行前后,对 14884 例患者队列的医院获得性血流感染的流行病学、时间进程和危险因素进行研究。
Infect Dis (Lond). 2023 Nov;55(11):776-785. doi: 10.1080/23744235.2023.2243327. Epub 2023 Sep 26.
6
Comparative incidence of early and late bloodstream and respiratory tract co-infection in patients admitted to ICU with COVID-19 pneumonia versus Influenza A or B pneumonia versus no viral pneumonia: wales multicentre ICU cohort study.伴有 COVID-19 肺炎、甲型或乙型流感肺炎与无病毒性肺炎的 ICU 住院患者的早期和晚期血流感染与呼吸道感染合并感染发生率的比较:威尔士多中心 ICU 队列研究。
Crit Care. 2022 Jun 2;26(1):158. doi: 10.1186/s13054-022-04026-9.
7
Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007.1997 - 2007年美国重症监护病房耐甲氧西林金黄色葡萄球菌中心静脉导管相关血流感染情况
JAMA. 2009 Feb 18;301(7):727-36. doi: 10.1001/jama.2009.153.
8
Bloodstream infections in the era of the COVID-19 pandemic: Changing epidemiology of antimicrobial resistance in the intensive care unit.新冠疫情时代的血流感染:重症监护病房抗菌药物耐药性流行病学的变化
J Intensive Med. 2024 Mar 27;4(3):269-280. doi: 10.1016/j.jointm.2023.12.004. eCollection 2024 Jul.
9
Socioeconomic position and the COVID-19 care cascade from testing to mortality in Switzerland: a population-based analysis.社会经济地位与瑞士从检测到死亡的 COVID-19 护理级联:基于人群的分析。
Lancet Public Health. 2021 Sep;6(9):e683-e691. doi: 10.1016/S2468-2667(21)00160-2. Epub 2021 Jul 10.
10
COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network.COVID-19 增加了 ICU 获得性血流感染的风险:来自多中心 OUTCOMEREA 网络的病例队列研究。
Intensive Care Med. 2021 Feb;47(2):180-187. doi: 10.1007/s00134-021-06346-w. Epub 2021 Jan 27.

引用本文的文献

1
Bloodstream Infections in Critical Care Units in England, April 2017 to March 2023: Results from the First Six Years of a National Surveillance Programme.2017年4月至2023年3月英格兰重症监护病房的血流感染:一项国家监测计划前六年的结果
Microorganisms. 2025 Jan 16;13(1):183. doi: 10.3390/microorganisms13010183.
2
Interrupted-time-series analysis of the impact of COVID-19 pandemic on blood culture utilization in Shanghai.新型冠状病毒肺炎疫情对上海血培养使用情况影响的间断时间序列分析
BMC Infect Dis. 2025 Jan 9;25(1):48. doi: 10.1186/s12879-025-10444-1.
3
Secondary Bacterial Infections in Critically Ill COVID-19 Patients Admitted in the Intensive Care Unit of a Tertiary Hospital in Romania.

本文引用的文献

1
Increased blood culture contamination rate during COVID-19 outbreak in intensive care unit: A brief report from a single-centre.重症监护病房新冠肺炎疫情期间血培养污染率升高:来自单中心的简要报告
J Intensive Care Soc. 2022 Nov;23(4):500-502. doi: 10.1177/17511437211012152. Epub 2021 Apr 30.
2
Bloodstream Infection Risk, Incidence, and Deaths for Hospitalized Patients during Coronavirus Disease Pandemic.在冠状病毒病大流行期间住院患者的血流感染风险、发病率和死亡率。
Emerg Infect Dis. 2021 Nov;27(10):2588-2594. doi: 10.3201/eid2710.210538. Epub 2021 Aug 5.
3
Increased rates of blood culture contamination during the coronavirus disease 2019 pandemic.
罗马尼亚一家三级医院重症监护病房收治的危重症新冠肺炎患者的继发性细菌感染
J Clin Med. 2024 Oct 18;13(20):6201. doi: 10.3390/jcm13206201.
4
Microbiology of bloodstream infections in Ontario, Canada during COVID-19 pandemic.加拿大安大略省新冠疫情期间血流感染的微生物学情况
Can Commun Dis Rep. 2024 Apr 30;50(3-4):114-118. doi: 10.14745/ccdr.v50i34a05.
5
Blood Stream Infections in COVID-19 Patients From a Tertiary Care Center in Lebanon: Causative Pathogens and Rates of Multi-Drug Resistant Organisms.黎巴嫩一家三级医疗中心的新冠病毒感染患者的血流感染:致病病原体和多重耐药生物体的发生率
Mayo Clin Proc Innov Qual Outcomes. 2023 Nov 24;7(6):556-568. doi: 10.1016/j.mayocpiqo.2023.10.001. eCollection 2023 Dec.
6
The impact of the COVID-19 pandemic on blood culture practices and bloodstream infections.COVID-19 大流行对血培养实践和血流感染的影响。
Microbiol Spectr. 2023 Dec 12;11(6):e0263023. doi: 10.1128/spectrum.02630-23. Epub 2023 Nov 17.
7
Incremental costs of hospital-acquired infections in COVID-19 patients in an adult intensive care unit of a tertiary hospital from a low-resource setting.资源匮乏环境下一家三级医院成人重症监护病房 COVID-19 患者医院获得性感染的增量成本。
Antimicrob Resist Infect Control. 2023 Apr 21;12(1):39. doi: 10.1186/s13756-023-01240-0.
8
Bloodstream Infections in SARS-CoV-2 Infected Patients: A Systematic Review.2019冠状病毒病感染患者的血流感染:一项系统评价
J Clin Med. 2023 Mar 14;12(6):2252. doi: 10.3390/jcm12062252.
9
Microbiology Clinical Culture Diagnostic Yields and Antimicrobial Resistance Proportions before and during the COVID-19 Pandemic in an Indian Community Hospital and Two US Community Hospitals.印度一家社区医院和美国两家社区医院在新冠疫情之前及期间的微生物学临床培养诊断率和抗菌药物耐药比例
Antibiotics (Basel). 2023 Mar 8;12(3):537. doi: 10.3390/antibiotics12030537.
10
Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study.COVID-19 与非 COVID-19 危重症患者血流感染的不同流行病学特征:Eurobact II 研究的描述性分析。
Crit Care. 2022 Oct 18;26(1):319. doi: 10.1186/s13054-022-04166-y.
新冠疫情期间血培养污染率上升。
Infect Control Hosp Epidemiol. 2022 Nov;43(11):1719-1721. doi: 10.1017/ice.2021.292. Epub 2021 Jun 24.
4
The Landscape of Candidemia During the Coronavirus Disease 2019 (COVID-19) Pandemic.COVID-19 大流行期间念珠菌血症的流行情况。
Clin Infect Dis. 2022 Mar 9;74(5):802-811. doi: 10.1093/cid/ciab562.
5
Bacteraemia variation during the COVID-19 pandemic; a multi-centre UK secondary care ecological analysis.新冠疫情期间菌血症的变化;英国多中心二级医疗生态分析。
BMC Infect Dis. 2021 Jun 11;21(1):556. doi: 10.1186/s12879-021-06159-8.
6
The interface between COVID-19 and bacterial healthcare-associated infections.新冠病毒与细菌所致的医疗保健相关性感染的界面。
Clin Microbiol Infect. 2021 Dec;27(12):1772-1776. doi: 10.1016/j.cmi.2021.06.001. Epub 2021 Jun 7.
7
Risk factors and clinical outcomes associated with blood culture contamination.与血培养污染相关的危险因素和临床结局。
Infect Control Hosp Epidemiol. 2022 Mar;43(3):291-297. doi: 10.1017/ice.2021.111. Epub 2021 Apr 26.
8
Bacteremia during COVID-19 pandemic in a tertiary hospital in Spain.西班牙一家三级医院在新冠疫情期间的菌血症情况。
Enferm Infecc Microbiol Clin (Engl Ed). 2021 Feb 11;40(4):183-6. doi: 10.1016/j.eimc.2021.01.015.
9
Community-acquired bacteraemia in COVID-19 in comparison to influenza A and influenza B: a retrospective cohort study.社区获得性细菌性血流感染在 COVID-19 中的表现与甲型流感和乙型流感的比较:一项回顾性队列研究。
BMC Infect Dis. 2021 Feb 22;21(1):199. doi: 10.1186/s12879-021-05902-5.
10
Coronavirus disease 2019 (COVID-19) pandemic, central-line-associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI): The urgent need to refocus on hardwiring prevention efforts.2019年冠状病毒病(COVID-19)大流行、中心静脉导管相关血流感染(CLABSI)和导尿管相关尿路感染(CAUTI):迫切需要重新聚焦于将预防措施落实到位。
Infect Control Hosp Epidemiol. 2022 Jan;43(1):26-31. doi: 10.1017/ice.2021.70. Epub 2021 Feb 19.